Literature DB >> 35484415

Dietary patterns in association with the expression of pro-metastatic genes in primary breast cancer.

Mitra Foroutan-Ghaznavi1,2,3, Seyed-Mohammad Mazloomi4,5, Vahid Montazeri6,7, Saeed Pirouzpanah8,9.   

Abstract

PURPOSE: Metastasis is a major leading cause of mortality in female breast cancer (BrCa). Cellular motility is a pathological process of metastasis remarked by the overexpression of cortactin (CTTN), Ras homolog family member-A (RhoA), and Rho-associated kinase (ROCK) genes. Their balance is responsible for upholding the integrity of healthy epithelial cell junctions. This study aimed to explore the associations between a posteriori dietary patterns and the expression levels of pro-metastatic genes in primary BrCa.
METHODS: In this consecutive case series, 215 eligible women, newly diagnosed with histologically confirmed non-metastatic BrCa (stage I-IIIA), were recruited from Hospitals in Tabriz, Northwestern Iran (2015-2017). The tumoral expression levels of genes were quantified using real-time reverse transcription-polymerase chain reaction. Dietary data assessment was carried out using a validated food frequency questionnaire.
RESULTS: Three dietary patterns were identified using principal component analysis (KMO = 0.699). Adherence to the "vegan" pattern (vegetables, fruits, legumes, nuts, seeds, and whole grains) was inversely associated with the expression levels of RhoA (ORAdj.T3vs.T1 = 0.24, 95%CI 0.07-0.79) and ROCK (ORAdj.T3vs.T1 = 0.26, 95%CI 0.08-0.87). In addition, the highest adherence to the "prudent" pattern (spices, seafood, dairy, and vegetable oils) decreased the odds of overexpressions at RhoA (ORAdj.T3vs.T1 = 0.26, 95%CI 0.08-0.84) and ROCK genes (ORAdj.T3vs.T1 = 0.29, 95%CI 0.09-0.95). The highest adherence to "Western" pattern (meat, processed meat, hydrogenated fat, fast food, refined cereals, sweets, and soft drinks) was a risk factor associated with the overexpression of RhoA (ORAdj.T3vs.T1 = 3.15, 95%CI 1.12-8.85).
CONCLUSION: Adherence to healthy dietary patterns was significantly associated with the downregulation of pro-metastatic genes. Findings provided new implications to advance the nutrigenomic knowledge to prevent the odds of over-regulations in pro-metastatic genes of the primary BrCa.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Breast cancer; Cortactin; Dietary pattern; Metastasis; ROCK; RhoA

Mesh:

Year:  2022        PMID: 35484415     DOI: 10.1007/s00394-022-02884-1

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   4.865


  76 in total

1.  Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.

Authors:  Brian L Rothschild; Ann H Shim; Amanda Gatesman Ammer; Laura C Kelley; Kimberly B Irby; Julie A Head; Lin Chen; Marileila Varella-Garcia; Peter G Sacks; Barbara Frederick; David Raben; Scott A Weed
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

Review 2.  Cancer invasion and the microenvironment: plasticity and reciprocity.

Authors:  Peter Friedl; Stephanie Alexander
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

Review 3.  Cortactin: a multifunctional regulator of cellular invasiveness.

Authors:  Kellye C Kirkbride; Bong Hwan Sung; Seema Sinha; Alissa M Weaver
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

4.  Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: a case-control study.

Authors:  Parvin Mehdipour; Saeed Pirouzpanah; Majid Kheirollahi; Morteza Atri
Journal:  Breast J       Date:  2010-12-16       Impact factor: 2.431

Review 5.  Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis.

Authors:  Robert J Eddy; Maxwell D Weidmann; Ved P Sharma; John S Condeelis
Journal:  Trends Cell Biol       Date:  2017-04-12       Impact factor: 20.808

6.  The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.

Authors:  Wen-Chiuan Tsai; Chih-Kung Lin; Herng-Sheng Lee; Hong-Wei Gao; Shin Nieh; De-Chuan Chan; Jong-Shiaw Jin
Journal:  APMIS       Date:  2012-08-13       Impact factor: 3.205

7.  Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.

Authors:  Sang Jae Noh; Hyun Ah Baek; Ho Sung Park; Kyu Yun Jang; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Min Ho Kim; Ju Hyung Lee; Myoung Ja Chung
Journal:  Pathol Res Pract       Date:  2013-04-15       Impact factor: 3.250

8.  Cortactin and phosphorylated cortactin tyr421 and tyr466 expression in supraglottic laryngeal carcinomas and lymph node metastases.

Authors:  Gino Marioni; Marco Lionello; Rosario Marchese-Ragona; Elena Fasanaro; Elisa Valentini; Elisabetta Zanoletti; Paola Stritoni; Giulia Ramacciotti; Vincenza Guzzardo; Luciano Giacomelli; Giovanni Ralli; Giancarlo Ottaviano; Stella Blandamura
Journal:  Int J Biol Markers       Date:  2018-01       Impact factor: 2.659

9.  Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients.

Authors:  Parvin Mehdipour; Saeed Pirouzpanah; Abdolfattah Sarafnejad; Morteza Atri; S Tahereh Shahrestani; Mojgan Haidari
Journal:  Cell Biol Int       Date:  2009-06-23       Impact factor: 3.612

10.  Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.

Authors:  Tomer Meirson; Alessandro Genna; Nikola Lukic; Tetiana Makhnii; Joel Alter; Ved P Sharma; Yarong Wang; Abraham O Samson; John S Condeelis; Hava Gil-Henn
Journal:  Oncotarget       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.